Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
6.
Clin Exp Dermatol ; 48(12): 1381-1382, 2023 Nov 16.
Artigo em Inglês | MEDLINE | ID: mdl-37610826
11.
Clin Exp Dermatol ; 47(11): 2055-2058, 2022 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-36217259

RESUMO

We describe a dramatic presentation of a rare condition, presenting as a diffuse ecchymosis-like area. This entity has a predilection to primary cutaneous involvement, placing dermatologists as important primary assessors. Clinical knowledge and a high level of clinical suspicion are essential for timely diagnosis. Click here for the corresponding questions to this CME article.


Assuntos
Exantema , Púrpura , Humanos , Masculino , Púrpura/etiologia , Púrpura/patologia
17.
Dermatol Online J ; 17(4): 5, 2011 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-21549080

RESUMO

This case presents a 39-year-old gentleman with a single angiokeratoma on the abdomen. Because of a family history of early onset cardiac disease, testing for Fabry disease was performed and a mis-sense mutation (A143T) in the Fabry gene confirmed the diagnosis. The unusual aspect of this case is that the patient otherwise had normal health. His only detectable abnormality was a high serum creatinine at 116 mmol/L. Two further affected males and four carrier females were detected on family screening. We tested a further five patients with a single angiokeratoma for Fabry disease. In the five tested though, no suggestive personal or family history was given for any of the patients and no further cases were detected. This case highlights the need for vigilance within dermatology clinics to consider Fabry disease even if a solitary angiokeratoma is the only presenting feature. Some patients do display a milder phenotype and thus a detailed family history should always be taken. As in this case, a solitary angiokeratoma and a suspicious family history may be the only clue. Because enzyme replacement therapy is now available, the potential benefits for the patient and their family are high.


Assuntos
Angioceratoma/diagnóstico , Doença de Fabry/diagnóstico , Neoplasias Cutâneas/diagnóstico , Adulto , Angioceratoma/genética , Doença de Fabry/genética , Feminino , Humanos , Masculino , Mutação de Sentido Incorreto , Neoplasias Cutâneas/genética , alfa-Galactosidase/sangue , alfa-Galactosidase/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA